• KOLs Community
    • Cardiac
    • Cardiac Remodeling
    • Hana Linkova


      KOL Resume for Hana Linkova




      Hana Linkova: Influence Statistics

      Sample of concepts for which Hana Linkova is among the top experts in the world.
      Concept World rank
      fulacimstat tolerated #40
      inhibitor fulacimstat #54
      fulacimstat #54


      Prominent publications by Hana Linkova

      KOL-Index: 5125

      BACKGROUND: Adverse cardiac remodeling is a major risk factor for the development of post myocardial infarction (MI) heart failure (HF). This study investigates the effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute ST-segment-elevation myocardial infarction (STEMI).

      METHODS: In this double-blind, randomized, placebo-controlled trial patients with first STEMI were eligible. To preferentially enrich patients at high risk of adverse remodeling, main ...

      Known for Cardiac Remodeling | Myocardial Infarction | Chymase Inhibitor | Patients Randomized | Fulacimstat Tolerated
      KOL-Index: 1641

      BACKGROUND: Direct-acting oral anticoagulant use for stroke prevention in atrial fibrillation is limited by bleeding concerns. Asundexian, a novel, oral small molecule activated coagulation factor XIa (FXIa) inhibitor, might reduce thrombosis with minimal effect on haemostasis. We aimed to determine the optimal dose of asundexian and to compare the incidence of bleeding with that of apixaban in patients with atrial fibrillation.

      METHODS: In this randomised, double-blind, phase 2 ...

      Known for Atrial Fibrillation | Factor Xia

      Key People For Cardiac Remodeling

      Top KOLs in the world
      Jeffery D Molkentin
      cardiac hypertrophy heart failure muscular dystrophy
      Nikolaos Georgios Frangogiannis
      myocardial infarction cardiac fibrosis mast cells
      Marc Alan Pfeffer
      heart failure myocardial infarction preserved ejection fraction
      Joseph A Hill
      heart failure cardiac hypertrophy pregnancy loss
      Junichi Sadoshima
      cardiac myocytes heart failure pressure overload
      Eric N Olson
      skeletal muscle transcription factors gene expression

      Hana Linkova:Expert Impact

      Concepts for whichHana Linkovahas direct influence:Cardiac remodeling,  Chymase inhibitor,  Inhibitor fulacimstat,  Factor xia,  Fulacimstat tolerated,  Effects chymase.

      Hana Linkova:KOL impact

      Concepts related to the work of other authors for whichfor which Hana Linkova has influence:Cardiac remodeling,  Sacubitril valsartan,  Primary pci,  Factor xia,  Alternate component,  Chymase inhibitor,  Nash oxidative stress.



      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.